|
|
||||||||


* Institut de la Santé et de la Recherche Médicale Unité 519, Faculté de Médecine et de Pharmacie, Hôpital Charles-Nicolle, and
Laboratoire de Spectroscopie, Institut Fédératif de Recherches Multidisciplinaires sur les Peptides, Institut de Rechereche en Chimie Organique Fine, Rouen, France.
Immunoblots of a two-dimensional PAGE-separated HL-60 cell
proteomic map and mass spectrometry were combined to characterize
proteins targeted by autoantibodies produced by male (New Zealand
White x BXSB)F1 (WB) mice that develop lupus and
anti-phospholipid syndrome. Analysis of sera sequentially
obtained from seven individual mice at different ages showed that six
proteins, vimentin, heat shock protein 60, UV excision-repair protein
RAD23,
-enolase, heterogeneous nuclear ribonucleoprotein L, and
nucleophosmin, were the targets of the B cell autoimmune response, and
that autoantibodies to them were synthesized sequentially in an orderly
pattern that recurred in all the male WB mice analyzed:
anti-vimentin first and anti-nucleophosmin last, with
anti-RAD23 and anti-heat shock protein 60, then
anti-
-enolase and anti-heterogeneous nuclear
ribonucleoprotein L Abs occuring concomitantly. Anti-vimentin
reactivity always appeared before anti-cardiolipin and anti-DNA
Abs, suggesting that vimentin is the immunogen initiating the
autoimmune process. The pattern of HL-60 proteins recognized by female
WB sera differed from that of male sera, indicating that the Y
chromosome-linked autoimmune acceleration gene is not an accelerator
but a strong modifier of the autoimmune response. Thus, 1) combining
two-dimensional PAGE and mass spectrometry constitutes a powerful tool
to identify the set of Ags bound by autoantibodies present in a single
serum and the whole autoantibody pattern of an autoimmune disease; 2)
the diversification of the autoimmune response in male WB mice occurs
in a predetermined pattern consistent with Ag spreading, and thus
provides a useful model to further our understanding of the development
of the autoantibody response in
lupus.
This article has been cited by other articles:
![]() |
Y Dai, C Hu, Y Huang, H. Huang, J Liu, and T Lv A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus Lupus, September 1, 2008; 17(9): 799 - 804. [Abstract] [PDF] |
||||
![]() |
H. S. Leong, B. M. Mahesh, J. R. Day, J. D. Smith, A. D. McCormack, G. Ghimire, T. J. Podor, and M. L. Rose Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor J. Leukoc. Biol., February 1, 2008; 83(2): 263 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mahesh, H.-S. Leong, A. McCormack, P. Sarathchandra, A. Holder, and M. L. Rose Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac Allografts Am. J. Pathol., April 1, 2007; 170(4): 1415 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moisan and D. Girard Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis J. Leukoc. Biol., March 1, 2006; 79(3): 489 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dugue, R. Perraut, P. Youinou, and Y. Renaudineau Effects of Anti-Endothelial Cell Antibodies in Leprosy and Malaria Infect. Immun., January 1, 2004; 72(1): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |